Grifols

Grifols is a worldwide healthcare company, established in Barcelona in 1909, dedicated to enhancing the health and well-being of individuals across the globe. As a frontrunner in essential plasma-derived medicines and transfusion medicine, we develop, produce, and deliver cutting-edge healthcare services and solutions across more than 110 countries. Patient requirements, along with our expanding understanding of numerous chronic, rare, and prevalent conditions—some of which are life-threatening—guide our innovation in plasma-based therapies and other biopharmaceuticals aimed at improving quality of life. Grifols concentrates on addressing conditions spanning a wide array of therapeutic areas, including immunology, hepatology and intensive care, pulmonology, hematology, neurology, and infectious diseases. With a team of over 23,000 employees across more than 30 countries and regions, we are dedicated to a sustainable business model that establishes the benchmark for ongoing innovation, quality, safety, and ethical leadership within the industry. Our operations generate a beneficial social and economic influence in the nations where we function, creating employment opportunities and fostering wealth. People are central to our mission, and we aim to cultivate an inclusive, diverse, fair, and equitable society. Maintaining and encouraging a workforce that mirrors this principle enhances professional interactions and enables us to deliver our utmost to patients, donors, and customers. In 2025, Grifols was recognized by TIME as one of the ‘World’s Best Companies’ for the third consecutive year, underscoring our dedication to excellence. Additionally, Forbes acknowledged us as one of the "Best World Employers 2025," highlighting our commitment to promoting an inclusive and supportive work environment for everyone. To ensure a positive community and courteous interaction overall, we ask that you keep our community guidelines in mind.